BackgroundDespite our increased understanding of the mechanisms involved in acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS), there is no specific pharmacological treatment of proven benefit. We used a novel screening methodology to examine potential anti-inflammatory effects of a small structure-focused library of synthetic carbamate and urea derivatives in a well established cell model of lipopolysaccharide (LPS)-induced ALI/ARDS.Methodology/Principal FindingsAfter a pilot study to develop an in vitro LPS-induced airway epithelial cell injury model, a library of synthetic carbamate and urea derivates was screened against representative panels of human solid tumor cell lines and bacterial and fungal strains. Molecules that were non-cytotoxic and were inactive in terms of antiproliferative and antimicrobial activities were selected to study the effects on LPS-induced inflammatory response in an in vitro cell culture model using A549 human alveolar and BEAS-2B human bronchial cells. These cells were exposed for 18 h to LPS obtained from Escherichia coli, either alone or in combination with the test compounds. The LPS antagonists rhein and emodin were used as reference compounds. The most active compound (CKT0103) was selected as the lead compound and the impact of CKT0103 on pro-inflammatory IL-6 and IL-8 cytokine levels, expression of toll-like receptor-4 (TLR4) and nuclear factor kappa B inhibitor alpha (IκBα) was measured. CKT0103 significantly inhibited the synthesis and release of IL-6 and IL-8 induced by LPS. This suppression was associated with inhibition of TLR4 up-regulation and IκBα down-regulation. Immunocytochemical staining for TLR4 and IκBα supported these findings.Conclusions/SignificanceUsing a novel screening methodology, we identified a compound – CKT0103 – with potent anti-inflammatory effects. These findings suggest that CKT0103 is a potential target for the treatment of the acute phase of sepsis and sepsis-induced ALI/ARDS.
Pyrimidine derivativesPyrimidine derivatives R 0510 (6-Methyl-2-methylsulfanyl-4-oxo-3,4-dihydro-3-pyrimidinyl)acetic Acid and Related Compounds Exhibiting Antiinflammatory Activity. -The title acid (IV) and its amination products (VI) and (VIII) are synthesized and evaluated for their antiinflammatory activities. Most of the compounds obtained are found to be more active than acetylsalicylic acid and some of them, e.g. (IV), (VI) and (VIIIa) are significantly more active than ibuprofen. -(JAKUBKIENE*, V.; BURBULIENE, M. M.; UDRENAITE, E.; GARALIENE, V.; VAINILAVICIUS, P.; Pharmazie 57 (2002) 9, 610-613; Chem. Fac., Univ. Vilnius, Vilnius 2006, Lithuania; Eng.) -D. Singer 01-150
Several derivatives of the title compound (I) are prepared, e.g. S-alkylated derivatives (V), N-substituted derivatives (III) and (VIII), triazoles (IX) and (XIII), thiocarbohydrazides (X) and (XII). Most of the derivatives obtained are less toxic and show higher antiinflammatory activity than the reference drugs acetylsalicylic acid and ibuprofen. The most active derivatives are compounds (Vb) and (VIIIb). -(MEKUSKIENE, G.; BURBULIENE, M. M.; JAKUBKIENE, V.; UDRENAITE, E.; GAIDELIS, P.; VAINILAVICIUS, P.; Chem. Heterocycl.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.